Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation by Fink, Katrin et al.
Fink et al. Critical Care 2010, 14:R104
http://ccforum.com/content/14/3/R104
Open Access RESEARCH
BioMed  Central
© 2010 Fink et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons At-
tribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Research Severe endothelial injury and subsequent repair in 
patients after successful cardiopulmonary 
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Abstract
Introduction: Ischemia and reperfusion after cardiopulmonary resuscitation (CPR) induce endothelial activation and 
systemic inflammatory response, resulting in post-resuscitation disease. In this study we analyzed direct markers of 
endothelial injury, circulating endothelial cells (CECs) and endothelial microparticles (EMPs), and endothelial 
progenitor cells (EPCs) as a marker of endothelial repair in patients after CPR.
Methods: First we investigated endothelial injury in 40 patients after CPR, 30 controls with stable coronary artery 
disease (CAD), and 9 healthy subjects, who were included to measure CECs and EMPs. In a subsequent study, 
endothelial repair was assessed by EPC measurement in 15 CPR, 9 CAD, and 5 healthy subjects. Blood samples were 
drawn immediately and 24 hours after ROSC and analyzed by flow cytometry. For all statistical analyses P < 0.05 was 
considered significant.
Results: There was a massive rise in CEC count in resuscitated patients compared to CAD (4,494.1 ± 1,246 versus 312.7 
± 41 cells/mL; P < 0.001) and healthy patients (47.5 ± 3.7 cells/mL; P < 0.0005). Patients after prolonged CPR (≥30 min) 
showed elevated CECs compared to those resuscitated for <30 min (6,216.6 ± 2,057 versus 2,340.9 ± 703.5 cells/mL; P = 
0.13/ns). There was a significant positive correlation of CEC count with duration of CPR (R2= 0.84; P < 0.01). EMPs were 
higher immediately after CPR compared to controls (31.2 ± 5.8 versus 19.7 ± 2.4 events/μL; P = 0.12 (CAD); versus 15.0 ± 
5.2 events/μL; P = 0.07 (healthy)) but did not reach significance until 24 hours after CPR (69.1 ± 12.4 versus 22.0 ± 3.0 
events/μL; P < 0.005 (CAD); versus 15.4 ± 4.4 events/μL; P < 0.001 (healthy)). EPCs were significantly elevated in patients 
on the second day after CPR compared to CAD (1.16 ± 0.41 versus 0.02 ± 0.01% of lymphocytes; P < 0.005) and healthy 
(0.04 ± 0.01; P < 0.005).
Conclusions: In the present study we provide evidence for a severe endothelial damage after successful CPR. Our 
results point to an ongoing process of endothelial injury, paralleled by a subsequent endothelial regeneration 24 hours 
after resuscitation.
Introduction
The clinical course of patients after successful cardiopul-
monary resuscitation (CPR) is often complicated by post-
resuscitation disease, a condition of multiple life-threat-
ening disorders related to whole-body ischemia and rep-
erfusion syndrome [1,2]. This phenomenon shares many
features with severe sepsis, including a systemic inflam-
matory response with plasma cytokine elevation, coagu-
lation abnormalities, and myocardial dysfunction [3].
Ischemia, reperfusion and hypoxia during or after CPR
induce generalized tissue damage with release of reactive
oxygen species and endothelial-leukocyte interaction and
activation, resulting in increased microvascular permea-
bility and, hence, in loss of endothelial integrity [2]. Sev-
eral studies demonstrated an endothelial activation with a
consecutive endothelial injury following cardiac arrest [4-
6] and in models of ischemia and reperfusion [7,8].
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A new tool for evaluation of endothelial injury is detec-
tion of circulating endothelial cells (CECs): these cells
detach from the intima monolayer in response to
endothelial damage and become measurable in peripheral
blood. Although CECs are rarely found in the blood of
healthy individuals, raised numbers are present in
patients with a wide variety of diseases involving the
endothelium such as vasculitis [9], arterial occlusive dis-
ease [10], and cardiovascular disease [11]. There is a
strong relation between CECs and endothelial dysfunc-
tion because numbers of CECs correlate with surrogate
markers of disturbed endothelial function such as flow-
mediated dilation and von Willebrand factor (vWF) [12].
Plasma vWF is one of the most established plasma surro-
gate markers of endothelial damage or dysfunction [13].
VWF antigen concentrations are elevated on the second
day after CPR and seem to be an early predictor of out-
come [14].
Additionally, there is an increase of endothelial
microparticles (EMPs) in states of disturbed endothelial
function. Microparticles are small shed membranous ves-
icles (<1 μm) that are released from cells upon activation
or during apoptosis. They reflect the state of their paren-
tal cells in amounts and phenotypes [15]. Microparticles
have procoagulant properties, modulate endothelial func-
tion, and play a role in inflammatory processes [16].
EMPs were found to be elevated in peripheral blood of
patients suffering from acute coronary syndrome [17], or
peripheral arterial disease [18]. Circulating endothelial
progenitor cells (EPCs) are capable of repairing damaged
endothelium and furthermore contribute to re-endotheli-
alization and neovascularization [19]. These cells are
bone marrow-derived pluripotent vascular progenitor
cells that home in on the sites of ischemia and vascular
injury [20]. A decrease in EPC count in peripheral blood
is associated with endothelial dysfunction [21]. Patients
with coronary artery disease showed reduced levels of
EPCs [22] and there was an inverse correlation of number
of EPCs in the peripheral blood, increased atherosclerotic
risk factors, and a higher cardiovascular morbidity and
mortality [23].
In the present study, we hypothesize that endothelial
injury takes place during and after CPR, which in turn
may contribute to post-resuscitation disease. Therefore,
the aim of the present study is to detect direct markers of
endothelial damage such as CECs, EMPs and vWF, as well
as markers of endothelial repair (EPCs) in peripheral
blood of patients after successful CPR.
Materials and methods
Patients and blood sampling protocol
After the approval of the ethics committee of our institu-
tion for both studies (EK-Freiburg 115/07), we first
included 40 patients who underwent CPR after cardiac
arrest in a prospective study to measure endothelial
injury and compared them with 30 patients suffering
from stable coronary artery diseases (CAD) and 9 healthy
subjects. Subsequently, we prospectively included 15
resuscitated patients to detect endothelial repair. Nine
CAD patients and five healthy subjects served as con-
trols. As elevation of CECs, microparticles and EPCs have
been described to increase in various malignancies and in
severe sepsis, patients with malignant diseases and sepsis
were excluded from the study [24]. Patients younger than
18 years and trauma patients were also excluded.
Informed consent was obtained post hoc from patients
surviving with good neurological outcome, or from their
relatives in the case of nonsurviving patients. Informed
consent was given by all patients in the control groups.
Using an arterial catheter, blood samples in resuscitated
patients were collected immediately after admission to
the ICU and a second sample was collected 24 hours after
return to spontaneous circulation (ROSC) in the CEC
and EMP study. EPC study samples were collected on the
second day after ROSC. In control patients, blood was
drawn from the arterial catheter immediately after percu-
taneous coronary intervention (PCI). On the second day
after PCI and in controls who did not receive PCI, blood
was drawn by venopuncture. Samples were drawn slowly,
handled carefully and analyzed immediately after sam-
pling. For vein puncture, we used a 21-gauge butterfly
needle and discarded the first 7.5 mL.
Flow cytometric analysis was performed on a three-
color flow cytometer (FACSCalibur™, BD Biosciences,
San Jose, CA, USA) with individual settings for each anti-
body utilizing Cell Quest Pro™software (BD Biosciences,
San Jose, CA, USA).
Detection of CECs by flow cytometry analysis
For measurement of CECs, 2.5 mL of blood was collected
in EDTA tubes. CECs were detected by a commercially
available detection kit (Biocytex, Marseille, France)
according to the manufacturer's instructions. CECs were
isolated from whole blood by ferromagnetic separation
and stained with fluorochrome-labelled monoclonal anti-
bodies (mAb), namely anti-human fluorescein isothiocy-
anate (FITC)-CD45 and anti-human PE-CD146 for cell
detection or anti-human FITC-CD45 and anti-mouse PE-
IgG serving as control, respectively. Tubes were analyzed
by flow cytometry analysis. Cells larger than the counting
beads and with at least the granularity of lymphocytes
were gated after identification on the forward/sideward
scatter. In this gate, CECs were identified as positive for
the specific marker CD146 (melanoma cell adhesion mol-
ecule (MCAM), a cell-adhesion molecule used as a
marker for endothelial cell lineage) and negative for the
hematopoietic marker CD45 (PTPRC, present on all dif-Fink et al. Critical Care 2010, 14:R104
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ferentiated hematopoietic cells; Figure 1). Samples were
analyzed at a flow rate of 60 μl/min for 200 seconds.
Detection of activated EMPs by flow cytometry analysis
For analysis of EMP, blood was collected in citrated tubes
and was centrifuged for 10 minutes at 240 g at room tem-
perature. Supernatant was diluted 1:50 with Tyrode buf-
fer, then incubated for 30 minutes at room temperature in
the dark with fluorochrome-labelled anti-human RPE-E-
selectin (Southern Biotech, Birmingham, AL, USA) to
detect EMPs or anti-mouse PE-IgG (Beckman Coulter,
Marseille, France) serving as controls. During incubation,
the cytometer was rinsed with FacsFlow™(BD Biosci-
ences, Erembodegem-Aalst, Belgium). After fixation of
the tubes with 300 μL of CellFix™(BD Biosciences, Erem-
bodegem-Aalst, Belgium), samples were ready to be ana-
lyzed by flow cytometry. Microparticles were gated by a
size of less than 1 μm using beads (Biocytex, Marseille,
France) with a defined size of 0.9 μm (Figures 2a and b).
Subsequently, microparticles positive for E-selectin
(CD62E), which originated from activated endothelial
cells were identified as activated EMPs (Figure 2c). Sam-
ples were analyzed at a flow rate of 12 μl/min for 180 sec-
onds.
Detection of EPCs by flow cytometry analysis
A 20 mL blood sample was used for enumeration of
EPCs. Samples were collected in EDTA tubes and kept on
ice at all times. Peripheral blood mononuclear cells were
isolated by Ficoll density-gradient centrifugation at 4°C,
resuspended in 1,000 μL of BSA 0.1% PBS and incubated
Figure 1 Flow cytometric detection of circulating endothelial 
cells in peripheral blood. Three-color flow cytometry evaluation of 
circulating endothelial cells (CECs). CD 146-positive and CD 45-nega-
tive cells were identified as CECs. In the panel, CEC appear on the up-
per left as a separate cell population (arrows).
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Figure 2 Flow cytometric detection of endothelial microparticles 
in peripheral blood. Three-color flow cytometry evaluation of en-
dothelial microparticles (EMPs). (a) Detection of particles with a size of 
less than 1 μm by nano-beads, (b) then gating of microparticles in the 
lower right. (c) Events staining positive for the fluorochrome-labelled 
antibody directed against E-selectin (CD62E) were identified as EMPs. 
FSC, forward scatter; SSC, side scatter.
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for 10 minutes. After centrifugation at 1,000 rpm for five
minutes at 4°C, the pellet was resuspended in 2 mL lysing
buffer (constituting of NH4Cl, KHCO3 and tetrasodium-
EDTA) and incubated for 10 minutes. Following a further
centrifugation at 1,000 rpm for five minutes at 4°C and
discarding supernatant, the pellet was washed twice in
PBS and resuspended in 100 μL PBS. Thereafter, samples
were incubated for 30 minutes in the dark with the fol-
lowing fluorochrome-labelled mAbs: 10 μL of anti-
human FITC-CD34 (BD Biosciences, San Jose, CA, USA),
anti-human PE-AC133 (Miltenyi Biotec GmbH, Auburn,
CA, USA), and anti-human RPE-vascular endothelial
growth factor-receptor 2 (VEGF-R2) (R&D Systems,
Minneapolis, MN, USA), or anti-mouse FITC-/PE-IgG
(Beckman Coulter, Marseille, France). Having washed the
pellet twice with PBS, it was resuspended in 500 μL Cell-
Fix™(BD Biosciences, Erembodegem-Aalst, Belgium).
Thereafter, tubes were ready for flow cytometry analysis.
We measured 10,000 events in a lymphocyte gate. Triple-
positive cells were identified by the expression of VEGF-
R2 within the double-positive CD34+/CD133+ popula-
tion gated. The number of EPCs was expressed as per-
centage of triple-positive cells of all lymphocytes.
Measurement of vWF in resuscitated patients
In resuscitated patients, analysis was accompanied by
photometric measurement of plasma vWF levels in the
central laboratory of the university hospital Freiburg.
Levels were compared with normal values of our institu-
tional laboratory.
Statistical analysis
Data are presented as means with the standard error of
the mean and compared by Student's t-tests and Chi-
Quadrate tests. Correlations between selected variables
were estimated by Spearman's rank correlation coeffi-
cient. All tests were two-sided and a level of P less than
0.05 was accepted as significant. Data was analyzed with
SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
In all resuscitated patients, overall duration of mechani-
cal resuscitation varied from 5 to 120 minutes (mean 23.2
± 2.7 minutes). The presenting initial rhythm was ven-
tricular fibrillation or ventricular tachycardia in 58%,
asystole or pulseless electrical activity in 42%. Fourty-two
patients (76%) presented a presumable cardiac cause for
cardiac arrest and 29 patients (53%) survived 10 days or
more in the ICU (Table 1).
As more of the CPR patients in the smaller EPC study
population presented ventricular fibrillation or ventricu-
lar tachycardia as the initial rhythm compared with
patients in the CEC and EMP study (87% vs. 67%), dura-
tion of CPR in the EPC study group was shorter (27.3 ±
3.5 minutes vs. 12.3 ± 2.0 minutes), and outcome was bet-
ter (survival ≥10 days in 67% vs. 48% of patients). Patients
in the EPC study were showing higher rates of out-of-
hospital cardiac arrests (87% vs. 67%), and a lower inci-
dence of acute renal failure (7% vs. 23%) compared with
resuscitated patients in the CEC and EMP study (Table
1).
Average time from ROSC to blood sampling was 2
hours 48 minutes ± 17 minutes in the CEC and EMP
study. The second blood sample was collected 26 hours
45 minutes ± 1 hour 15 minutes after ROSC. Blood sam-
ples in the EPC study were collected on the second day
after ROSC.
Comparing all patients in both studies, patients of the
resuscitation and CAD group were comparable in base-
line characteristics such as gender and age at time of
investigation (65.7 ± 1.8 years in the resuscitation group
vs. 64.3 ± 2.3 years in the control group; P = 0.32 not sig-
nificant (ns)). Of the resuscitated patients, 73% were pre-
senting significant CAD versus 95% of the control group.
Most of the patients in both groups underwent coronary
angiography (75% in the resuscitation group and 69% in
the CAD group). There were differences in the cardiovas-
cular risk profile of the two groups: CAD patients had a
higher incidence of hyperlipidemia (16% vs. 44%; P  <
0.05) and a trend to a higher prevalence of CAD and,
hence, more of them were treated with statins (27% vs.
59%; P < 0.01). The groups had a comparable profile of
secondary disorders including pulmonary disease, and
renal and liver insufficiency (Table 1).
All measurements were also performed in healthy con-
trols (nine in the CEC and EMP study and five in the EPC
study), taking no medication and carrying no cardiovas-
cular risk. Age at time point of investigation in the two
groups was 30.5 ± 1.1 years and 37 ± 7 years, respectively.
Detection of CECs by flow-cytometry analysis and 
correlation with duration of CPR
After CPR, we found a highly increased number of CECs
in resuscitated patients. The mean number of CECs was
4,494.1 ± 1,246 cells/mL in patients after CPR. The num-
ber of CECs in resuscitated patients was significantly
higher than in patients with stable CAD (mean number
312.7 ± 41 cells/mL; P < 0.005) and in healthy controls
(mean number 47.5 ± 3.7 cells/mL; P < 0.0005; Figure 3).
Patients who underwent prolonged CPR of 30 minutes or
longer showed substantially elevated levels of circulating
endothelial cells (mean number 6,216.6 ± 2,057 cells/mL)
compared with patients resuscitated less than 30 minutes
(mean number 2,340.9 ± 703.5 cells/mL; P = 0.13; ns). As
depicted in Figure 4, CEC counts showed a significantly
positive correlation with duration of CPR (R2 = 0.84; P <
0.01; Figure 4).F
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Table 1: Basic data of CPR and CAD patients
CPR group CAD group P value
Group CEC + EMP EPC All CEC + EMP EPC All
Number of patients n = 40 n = 15 n = 55 n = 30 n = 9 n = 39
Age (years) 65.3 ± 2.2 66.8 ± 3.1 65.7 ± 1.8 64.9 ± 2.8 67 ± 4.3 64.3 ± 2.3 0.32/ns
Gender Male 32 (80%) 10 (67%) 42 (76%) 26 (87%) 6 (67%) 32 (82%) 0.63/ns
Female 8 (20%) 5 (33%) 13 (24%) 4 (13%) 3 (33%) 7 (18%)
Location of CPR in-hospital 13 (33%) 2 (13%) 15 (27%)
out-of-hospital 27 (67%) 13 (87%) 40 (73%)
Duration of CPR (min) 27.3 ± 3.5 12.3 ± 2 23.2 ± 2.7
Initial rhythm VF/VT 21 (52%) 11 (73%) 32 (58%)
Asystole/PEA 19 (48%) 4 (27%) 23 (42%)
Cause of cardiac arrest or hospital admission Cardiac 29 (72%) 13 (87%) 42 (76%) 30 (100%) 8 (89%) 38 (97%) 0.11/ns
Non-cardiac 11 (28%) 3 (20%) 14 (24%) 0 (0%) 1 (11%) 1 (3%)
Coronary angiography 27 (68%) 14 (93%) 41 (75%) 21 (70%) 6 (66%) 27 (69%) 0.62/ns
Outcome Survival <10 days 21 (52%) 5 (33%) 26 (47%) 0 (0%) 0 (0%) 0 (0%)
Survival ≥ 10 days 19 (48%) 10 (67%) 29 (53%) 30 (100%) 9 (100%) 39 (100%)
Medication Vasopressors 32 (80%) 15 (100%) 47 (85%) 0 (0%) 0 (0%) 0 (0%)
Statins 14 (35%) 1 (7%) 15 (27%) 20 (67%) 3 (33%) 23 (59%) <0.05
Consecutive organ failure Acute heart failure 10 (25%) 3 (20%) 13 (24%) 0 (0%) 0 (0%) 0 (0%)
Acute renal failure 9 (23%) 1 (7%) 10 (18%) 0 (0%) 0 (0%) 0 (0%)
Acute liver failure 2 (1%) 0 (0%) 2 (4%) 0 (0%) 0 (0%) 0 (0%)F
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Co-morbidities CAD 26 (65%) 14 (93%) 40 (73%) 30 (100%) 7 (77%) 37 (95%) 0.09/ns
PAD 6 (15%) 5 (33%) 11 (20%) 10 (33%) 1 (11%) 11 (28%) 0.25/ns
Congestive heart failure 6 (15%) 1 (7%) 7 (13%) 6 (20%) 3 (33%) 9 (23%) 0.10/ns
Pulmonary disease 12 (30%) 3 (20%) 15 (27%) 6 (20%) 4 (44%) 10 (26%) 0.89/ns
Renal insufficiency 20 (50%) 6 (40%) 26 (47%) 8 (27%) 4 (44%) 12 (31%) 0.07/ns
Liver insufficiency 7 (18%) 1 (7%) 8 (15%) 3 (10%) 0 (0%) 3 (8%) 0.14/ns
Cardiovascular risk factors Hypertension 22 (55%) 4 (27%) 26 (47%) 17 (57%) 4 (44%) 21 (54%) 0.49/ns
Diabetes 11 (28%) 5 (33%) 16 (29%) 3 (10%) 1 (11%) 4 (10%) <0.05
Hyperlipidemia 8 (20%) 1 (7%) 9 (16%) 15 (50%) 2 (22%) 17 (44%) <0.01
Smoking 8 (20%) 5 (33%) 13 (24%) 10 (33%) 4 (44%) 14 (36%) 0.12/ns
Basic data of the resuscitation group, including initial rhythm, outcome, location, and duration of CPR, and comparison of clinical variables in the CPR and CAD group. Both groups are comparable 
in baseline variables including age, gender, probable cause of cardiac arrest/cause of hospital admission, incidence of CAD, coronary angiography, congestive heart failure, and other relevant 
secondary disorders. There are slight but significant differences in distribution of cardiovascular risk factors as well as co-medication with statins.
CAD, coronary artery disease; CEC, circulating endothelial cells; CPR, cardiopulmonary resuscitation; EMP, endothelial microparticles; EPC, endothelial progenitor cells; ns, not significant; PAD, 
peripheral artery disease; PEA, pulseless electrical activity; VF, ventricular fibrillation; VT, ventricular tachycardia.
Table 1: Basic data of CPR and CAD patients (Continued)Fink et al. Critical Care 2010, 14:R104
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Detection of activated EMPs by flow cytometry analysis
As a second marker of endothelial injury, we investigated
the presence of EMPs in the peripheral blood of resusci-
tated patients. Microparticles are characterized by size
(that typically ranges from 0.1 to 1.0 μm) and exposure of
antigens that reflect origin and activation state of the cells
they originate from. Here, we chose E-selectin as a
marker of endothelial cell activation. The mean number
(31.2 ± 5.8 events/μL) was slightly increased immediately
after CPR but did not differ significantly from CAD
patients (mean number 19.7 ± 2.4 events/μL; P = 0.12) or
healthy controls (mean number 15.0 ± 5.2 events/μL; P =
0.07). Twenty-four hours after ROSC, the mean numbers
of EMPs (69.1 ± 12.4 events/μL) in resuscitated patients
were significantly higher than in the CAD group (mean
number 22.0 ± 3.0 events/μL; P < 0.005) and in healthy
subjects 15.4 ± 4.4 events/μL; P  < 0.001; Figure 5). In
addition, in patients after successful resuscitation the
number of EMPs increased significantly in the first 24
hours (P < 0.01). In controls, there was no significant dif-
ference between numbers of EMPs in a follow up of 24
hours (CAD: P = 0.55; healthy: P = 0.95).
Nine of the patients included, who were pre-treated
with statins, immediately showed slightly lower EMP
counts (22.3 ± 5.7 vs. 41.3 ± 12.6 events/μL; P = 0.23) and
24 hours after ROSC (62.6 ± 19.9 vs. 81.1 ± 19.2 events/
μL; P = 0.49) compared with those without statin pre-
treatment.
Detection of EPC by flow cytometry analysis
To assess vascular repair following endothelial injury in
patients after CPR, circulating EPCs were measured in
peripheral blood of resuscitated patients in a follow-up
study. Percentage of circulating EPCs in resuscitated
patients were significantly higher than in control patients
(1.16 ± 0.41% of gated lymphocytes in patients after CPR
versus 0.02 ± 0.01% of gated lymphocytes (P < 0.005) in
CAD and 0.04 ± 0.01% of gated lymphocytes (P < 0.005)
in healthy controls; Figure 6). EPCs were identified by
Figure 3 Elevation of circulating endothelial cells in patients after 
CPR. Levels of circulating endothelial cells (CEC) in peripheral blood 
obtained from healthy subjects, patients with coronary artery disease 
(CAD) and after cardiopulmonary resuscitation (CPR) for less than 30 
minutes (CPR <30 min) and longer than 30 minutes (CPR ≥30 min), and 
in all resuscitated patients (CPR all). The number of CEC in all resuscitat-
ed patients was significantly higher compared with those in both con-
trol groups. *** P < 0.0005 versus control; ** P < 0.005 versus control.
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Figure 4 Positive correlation of CEC count with duration of CPR. 
Correlation between circulating endothelial cell (CEC) counts and the 
duration of cardiopulmonary resuscitation (CPR) showing a significant 
positive correlation. The rising numbers of CEC in peripheral blood 
with longer duration of resuscitation suggest a greater extent of en-
dothelial damage during ongoing CPR (correlation coefficient 0.84; P < 
0.01).
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Figure 5 Elevated endothelial microparticles in patients after 
CPR. Levels of endothelial microparticles (EMPs) in peripheral blood 
obtained immediately after restoration of cardiopulmonary resuscita-
tion (CPR; left) and 24 hours after return to spontaneous circulation 
(right) from healthy subjects (white bars), patients with coronary artery 
disease (CAD; grey bars) and after CPR (black bars). The number of 
EMPs in resuscitated patients immediately after return to spontaneous 
circulation was slightly higher compared with both control groups, 
showing a significant difference compared with controls 24 hours after 
return to spontaneous circulation). There is a significant rise in EMPs 
when comparing the two points in time after return to spontaneous 
circulation in the resuscitation group, reflecting an ongoing endothe-
lial damage in the first 24 hours after CPR. *** P < 0.001 versus control; 
** P < 0.005 versus control; * P < 0.01 versus control; ns, statistically not 
significant versus control.
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flow cytometry analysis as cells positive for CD34
(expressed on developmentally early stem and progenitor
cells), CD133 (a marker expressed on immature cells) and
VEGF-R2 (receptor mediating almost all of the known
cellular responses to VEGF and essential for engraftment
of hematopoietic stem and progenitor cells).
vWF levels in resuscitated patients and correlation with 
other markers
Resuscitated patients showed significant elevated plasma
levels of vWF immediately (296.5 ± 73.4%; P < 0.05) and
24 hours after ROSC (304.4 ± 22.8%; P < 0.001), com-
pared with normal values of our institutional laboratory
(50 to 160%), indicating endothelial damage or dysfunc-
tion. Furthermore, vWF levels in resuscitated patients
correlated significantly with CEC count (R2 = 0.77; P <
0.05; Figure 7).
Discussion
The vascular endothelium lining the blood vessels is one
of the most complex and sensible organ systems. Its
integrity is an important precondition for a regular func-
tion of the circulatory system. The endothelium governs a
host of fundamental physiologic functions: endothelial
cells serve as signal transduction cells for a variety of
chemical and mechanical stimuli, produce cytokines, or
other paracrine signalling molecules, regulate leukocyte
adhesion and migration, and maintain the balance
between pro- and anticoagulant mechanisms [25,26].
The data presented in this report show the occurrence
of severe endothelial damage in patients after successful
CPR, and in a follow-up study, of a subsequent endothe-
lial regeneration. In summary, we found a rapid and
severe increase in CECs directly after CPR and a delayed
increase in EMPs. This was paralleled by elevated levels
of vWF, immediately and 24 hours after ROSC, compared
with normal values. We chose vWF to support the flow
cytometric measurements by a conventional and well-
established marker of disturbed endothelium [13]. As lev-
els of vWF showed a positive correlation with CEC count
in resuscitated patients, these data underline the reliabil-
ity of CEC count in the detection of endothelial damage.
These results indicate early endothelial damage and
ongoing endothelial dysfunction detected by elevated
CECs and EMPs in resuscitated patients compared with
control groups. Furthermore, numbers of EPCs increased
on the second day after ROSC, which points to an early
initiation of endothelial regeneration. The direct compar-
ison with patients with stable CAD undergoing coronary
intervention excluded effects possibly caused by CAD or
coronary intervention.
In this study we could also demonstrate a significant
positive correlation between the CEC count and the
duration of CPR. In the literature, a long period of isch-
emia and longer duration of resuscitation efforts are asso-
ciated with poor outcome [27,28], and the timing of the
ischemic insult and the length of the reperfusion have
been shown to correlate with endothelial dysfunction
variables and biochemical or histological evidence for cel-
lular damage [25,29]. Therefore, the correlation described
in this study might reflect a greater extent of endothelial
damage occurring during longer periods of CPR. How-
Figure 6 Elevation of endothelial progenitor cells in patients af-
ter CPR. Three-color flow cytometry evaluation of endothelial progen-
itor cells (EPCs) in healthy subjects (left), patients with coronary artery 
disease (CAD; middle) and after cardiopulmonary resuscitation (CPR; 
right). EPC count, expressed in percentage of gated lymphocytes, was 
significantly higher in resuscitated patients compared with both con-
trol groups, pointing to early onset of endothelial repair after CPR. ** P 
< 0.005 versus control.
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Figure 7 Positive correlation of CEC count with von Willebrand 
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ever, we have to state that this positive correlation is
largely due to a small number of patients with a long
duration of CPR with CEC values outside the data cloud.
After cardiac arrest and mechanical resuscitation, there
is growing evidence for an ischemia and reperfusion syn-
drome resulting in several inflammation cascades,
including activation of leucocytes [30], up-regulation of
selectins [4,6], and adhesion molecules [5,31] on the sur-
face of the endothelium. Adrie and colleagues reported a
'sepsis-like syndrome' after resuscitation, with an
increase in circulating interleukins, TNF, and a general-
ized systemic inflammatory response [3]. Researchers
recently stated that an early toll-like receptor 4-induced
vascular injury might be an important trigger of the sys-
temic inflammatory response in resuscitated mice [32]. In
analogy to the data obtained in our study, there are
reports of elevated numbers of CECs in critically ill
patients presenting with acute respiratory distress syn-
drome [33] and severe inflammatory disease conditions
such as septic shock [34]. Hence, we excluded patients
with septic shock from the study. The relatively few
patients in the study with in-hospital arrests and the high
percentage of patients with cardiac-related arrest suggest
that most patients were not critically ill prior to cardiac
arrest. Moreover, in critically ill patients, who did not
undergo CPR, CEC counts were only slightly elevated
(comparable with the levels of the CAD group; data not
shown). Therefore, it seems to be unlikely that critical ill-
ness or ICU procedures themselves contribute to the ele-
vation of CECs. The currently available data does not
allow for a clear differentiation of whether the increase of
CECs is the cause or effect of the inflammatory reaction
taking place. The very early elevation of CECs to a vast
extent after CPR might be an indicator that endothelial
damage could be the initial step in post-resuscitation dis-
ease resulting in secondary inflammatory reactions. Con-
ceivable triggers for endothelial damage might be hypoxia
[30] or shear stress [35,36]. Therefore, it seems possible
that shear stress during mechanical chest compression or
the action itself is another cause of enhanced detachment
of CEC from the endothelial layer.
We obtained comparatively high absolute values of
CECs in this study, compared with the literature. In our
opinion this indicates massive endothelial damage after
CPR that largely exceeds the values detected in other dis-
eases described so far in the available literature. This
underlines the severity of this life-threatening condition,
associated with complete discontinuation of circulation
and high mortality. On the other hand, CEC counts in the
literature vary from 15 to 670 cells/mL in various disease
states [33,37], which points out the inhomogeneity of this
relatively new method. Furthermore, different methodi-
cal approaches might change the absolute values.
Interestingly, and in contrast to the CECs, the number
of EMPs in resuscitated patients rises further in the first
24 hours after ROSC, hence reflecting an ongoing process
of endothelial damage. As EMPs are elevated in several
systemic inflammatory diseases such as vasculitis [38]
and sepsis [39], the noticeable increase in EMP numbers
could be due to the systemic inflammatory response
occurring after CPR maintaining endothelial injury. EMP
may express adhesion molecules specific to mature
endothelial cells, such as platelet-endothelial cell adhe-
sion molecule-1 (CD31), VE-cadherin (CD144), or
MCAM (CD146). Activation of endothelial cells with
TNF-α induced the formation of EMPs [16] exposing
adhesion-cell molecules, including E-selectin (CD62E) or
intercellular adhesion molecule-1 (CD54). In this study,
we measured activation-induced EMPs by detection of E-
selectin-positive microparticles. A possible explanation
for the ongoing endothelial injury in the post-resuscita-
tion period could be ischemia and reperfusion during
cardiac arrest and mechanical resuscitation.
Interestingly, patients treated with statins prior to car-
diac arrest showed slightly lower EMP counts. These
results indicate a potential protective effect of statins on
the endothelium during and after ischemia and reperfu-
sion and encourage further investigation of the effect of
statin treatment in post-resuscitation care.
Finally, in a smaller population, we were able to detect
elevated numbers of EPC in patients on the second day
after CPR as an indicator of the early onset of endothelial
repair. EPC-mediated vascular repair has been shown to
be associated with normalization of endothelial function
and restoration of blood flow at the site of injury [21].
These circulating cells are capable of endothelial differen-
tiation and homing to ischemic tissues [20]. EPCs are
considered to originate from hematopoietic stem cells,
which are positive for CD34 and VEGF-R2 and immature
marker protein CD133 [40]. CD34+ blood cell counts are
w i d e l y  u s e d  t o  o b t a i n  ' m o b i l i z e d '  h e m a t o p o i e t i c  s t e m /
progenitor cells from peripheral blood [41]. Cate-
cholamines are known to induce angiogenesis in tumor
tissues [42] and dopamine has been shown to mobilize
EPCs from the bone marrow during tumor growth [43].
Nevertheless, norepinephrine failed to increase CD34+
levels in heart failure patients [44]. In the EPC study
group, all CPR patients received vasopressors such as
norepinephrine and epinephrine but none of them
received dopamine. Moreover, a small control group of
critically ill patients at our ICU, who did not undergo
CPR but received vasopressors and mechanical ventila-
tion, showed no elevation of EPCs (data not shown).
However, we cannot exclude the possibility of any influ-
ence of catecholamines or ICU procedures administered.
A limitation of the present study is its observatory
design. Further experimental studies could allow a moreFink et al. Critical Care 2010, 14:R104
http://ccforum.com/content/14/3/R104
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detailed investigation of causes and effects of endothelial
damage in post-resuscitation disease. Moreover, experi-
mental studies would allow the assessment of possible
therapeutic interventions. In the current study, the num-
ber of patients was rather small, particularly in the EPC
study. However, the described effects are overwhelming
and obtain clear statistical significance.
Conclusions
In this study we provide evidence for an endothelial
injury occurring in patients after CPR. The obtained data
suggest a two-step process: The early stage during and
directly after CPR is prevailed by severe endothelial dam-
age. Within the following 24 hours, inflammation and
endothelial repair are taking place. These results could be
the basis for further interventional studies with the aim of
developing new therapeutic and prognostic strategies in
post-resuscitation care. As a perspective, endothelial pro-
tection (e.g. statins), anti-inflammatory drugs (e.g. corti-
costeroids), as well as regenerative therapies (e.g. growth
factors) could be promising future therapeutic strategies
in the early phases after CPR.
Key messages
• Patients after successful CPR show an early and
severe endothelial injury.
• Endothelial microparticles, as a sign of endothelial
inflammation, rise within the first 24 hours after
ROSC.
• On the second day after successful CPR, patients
present elevated markers of endothelial repair.
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